HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

butyrimidylpyridine disulfide- insulin

insulin deriv used in the preparation of insulin-enzyme conjugates
Also Known As:
insulin, butyrimidylpyridine disulfide-; BPDSI; butyrimidylpyridine disulfide insulin; Insulin, NA-(1-imino-4-(2-pyridinyldithio)butyl)-
Networked: 24 relevant articles (1 outcomes, 4 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Bellino, Silvio: 11 articles (11/2021 - 09/2005)
2. Arntz, Arnoud: 8 articles (01/2022 - 02/2003)
3. Bozzatello, Paola: 6 articles (11/2021 - 02/2014)
4. Bogetto, Filippo: 4 articles (02/2014 - 09/2005)
5. Rocca, Paola: 3 articles (11/2021 - 09/2017)
6. Paradiso, Erika: 3 articles (11/2008 - 09/2005)
7. Aguglia, Eugenio: 2 articles (04/2018 - 01/2017)
8. BRT Group: 2 articles (04/2018 - 01/2017)
9. Barone, Lavinia: 2 articles (04/2018 - 01/2017)
10. Carpiniello, Bernardo: 2 articles (04/2018 - 01/2017)

Related Diseases

1. Borderline Personality Disorder (Personality Disorders, Borderline)
04/01/2018 - "Clinical diagnosis and assessment of the severity of manifestations might be improved through the administration of structured interviews such as the Borderline Personality Disorder Severity Index, 4th edition (BPDSI-IV). "
01/01/2022 - "In this qualitative study, using a semi-structured interview followed by thematic analysis using Atlas.ti, we focused on experiences of therapists and patients with a disorder specific ROM instrument: the Borderline Personality Disorder Severity Index-IV (BPDSI-IV). "
01/01/2013 - "Although the borderline personality disorder severity index--version IV (BPDSI-IV) has already been used in several studies, psychometric properties are only known from two developing studies. "
02/01/2003 - "The psychometric properties and validity of the Borderline Personality Disorder Severity Index (BPDSI), a semistructured interview assessing the frequency and severity of manifestations of Borderline Personality Disorder (BPD) during a circumscribed period, were investigated in two studies. "
12/01/2023 - "Patients were assessed at baseline and after 20 weeks with: the Clinical Global Impression Scale, Severity item (CGI-S); the Social Occupational Functioning Assessment Scale (SOFAS); the Satisfaction Profile (SAT-P); the Borderline Personality Disorder Severity Index (BPDSI); the Modified Overt Aggression Scale (MOAS); the Childhood Trauma Questionnaire - Short Form (CTQ-SF); the Inventory of Interpersonal Problems (IIP-32); and the Reading the Mind in the Eyes Test (RMET). "
2. Personality Disorders (Personality Disorder)
3. Bipolar Disorder (Manic Depressive Psychosis)
4. Mania (Manias)
5. Major Depressive Disorder (Major Depressive Disorders)

Related Drugs and Biologics

1. Fatty Acids (Saturated Fatty Acids)
2. Oxcarbazepine (Trileptal)
3. beta-apocarotenoid-14',13'-dioxygenase (ADO)
4. 3,4-methylenedioxyethamphetamine (MDEA)

Related Therapies and Procedures

1. Aftercare (After-Treatment)